Simona Mezzacappa

Plain English
This study looked at how a treatment called nickel oral hyposensitization (NiOHT) affects the quality of life for people with systemic nickel allergy syndrome (SNAS). Researchers found that after one year of treatment, patients reported a 20% improvement in their overall health-related quality of life. This is important because it shows that NiOHT can significantly help those suffering from this allergy feel better and improve their daily lives. Who this helps: This helps patients with systemic nickel allergy syndrome.

Plain English
This study looked at how effective latex immunotherapy is for people allergic to natural rubber latex. Researchers treated 76 patients with this therapy for over three years and found that the size of skin reactions to latex decreased, along with specific allergy-related antibodies in the blood. This is important because it shows that this treatment can reduce allergy symptoms and improve quality of life for those affected. Who this helps: This benefits patients with latex allergies seeking relief from their symptoms.

Plain English
In this study, researchers looked at 13 patients with food allergies who underwent a treatment called specific oral desensitization to see if they could maintain their tolerance to certain foods after stopping the treatment. They found that all patients initially became desensitized, but when they stopped eating the allergens, 12 out of 13 had allergic reactions when they reintroduced these foods later. This indicates that the tolerance gained from the treatment is temporary, and regular consumption of the allergens is needed to keep that tolerance. Who this helps: This information benefits patients with food allergies and their doctors by clarifying the need for ongoing exposure to allergens after desensitization.

Plain English
In this study, researchers looked at how effective a treatment called profilin desensitization is for patients with allergies to plant-based foods. They treated seven patients by gradually increasing their exposure to profilin, and found that after the treatment, five patients had less severe allergic reactions when tested, and all of them could eat foods they previously couldn't without reacting. This matters because it shows that this treatment can help people manage their food allergies safely. Who this helps: Patients with plant-based food allergies.

Plain English
This study looked at whether a drug called ertapenem could be safely given to patients who are allergic to certain antibiotics known as β-lactams. Out of 49 patients tested, 35 were able to safely receive ertapenem after showing negative allergy tests. This is important because it suggests that many patients with β-lactam allergies may not need to avoid carbapenem antibiotics, which can be critical for treating infections. Who this helps: This benefits patients with β-lactam allergies who require antibiotic treatment.

Plain English
This study looked at how many patients in central and southern Italy are allergic to three common allergens found in fruits and vegetables: lipid transfer proteins (LTP), profilin, and PR-10. Out of 120 patients tested, 76 were allergic to LTP, 14 to profilin, and 5 to PR-10. Most patients with LTP allergies experienced serious reactions, while those allergic to profilin mostly had mild oral symptoms. This is important because it highlights that LTP should be recognized as a significant food allergen in this region. Who this helps: This information is beneficial for patients with food allergies and doctors treating them.

Plain English
This study looked at how well a blood test, called the Basophil Activation Test (BAT), can track if people with cow's milk allergies become tolerant to milk after a special treatment called oral desensitization. In three male patients who went through this treatment, the results showed that while their specific allergy antibodies (IgE) went down, a different type of antibody (IgG4) went up, and the blood tests indicated that their allergic reactions to milk proteins were significantly reduced. This matters because it suggests that the BAT can effectively monitor the progress of treatment and the development of tolerance in food allergy patients. Who this helps: This helps patients with cow's milk allergies and their doctors.